Adaptive Extracorporeal Blood Treatment Systems for Niche Environments

Publication ID: 24-11857715_0009_PTD
Published: October 28, 2025
Category:Specialized Variations & Niche Solutions

Legal Citation

pr1or.art Inc., “Adaptive Extracorporeal Blood Treatment Systems for Niche Environments,” Published Technical Disclosure No. 24-11857715_0009_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857715_0009_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,715.

Summary of the Inventive Concept

A family of extracorporeal blood treatment systems tailored for specific, high-stakes environments, including high-security facilities, disaster relief scenarios, extreme weather conditions, and areas with limited medical resources.

Background and Problem Solved

The original patent disclosed an extracorporeal blood treatment apparatus with a blood-warming device. However, this design lacks adaptability for unique operational environments. The new inventive concept addresses this limitation by introducing specialized variations of the apparatus, ensuring reliable and efficient blood treatment in challenging situations.

Detailed Description of the Inventive Concept

The new claims describe four distinct embodiments: 1) a high-security system with tamper-evident sensors; 2) a disaster relief method using portable, battery-powered energy sources; 3) a portable apparatus for extreme weather conditions, housed in a waterproof and insulated casing; and 4) a system for areas with limited medical resources, featuring a simplified user interface and automated priming and calibration procedures. Each embodiment leverages the core concept of the original patent while incorporating innovative modifications to address specific niche requirements.

Novelty and Inventive Step

The new claims introduce novel features and combinations that are not obvious from the original patent, such as tamper-evident sensors, portable energy sources, and simplified user interfaces. These inventive steps provide a significant advancement in extracorporeal blood treatment technology, enabling reliable and efficient treatment in previously underserved environments.

Alternative Embodiments and Variations

Alternative embodiments could include integrating advanced sensors for real-time monitoring, incorporating artificial intelligence for predictive maintenance, or designing modular systems for easy transportation and deployment. These variations would further expand the inventive concept's scope and adaptability.

Potential Commercial Applications and Market

The adaptive extracorporeal blood treatment systems have significant commercial potential in various industries, including healthcare, disaster relief, and military operations. Target markets include high-security facilities, emergency response organizations, and medical providers operating in challenging environments.

CPC Classifications

SectionClassGroup
A A61 A61M1/369
A A61 A61M1/3623
A A61 A61M1/3626
A A61 A61M1/3627
A A61 A61M1/3643
A A61 A61M39/28
A A61 A61M2205/3344
A A61 A61M2205/36

Original Patent Information

Patent NumberUS 11,857,715
TitleExtracorporeal blood treatment apparatus
Assignee(s)Gambro Lundia AB